Form D · Biotechnology
iTolerance, Inc.
Miami, FL · CIK 0001828948
Offering snapshot reported Feb 4, 2022 · SEC filing
- Reported sold
- $17.2M Offering amount: $20M
- Investors reported
- 144 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 9, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$5,229,500 → $17,164,500
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2022 | Amendment | $17,164,500 | $11,935,000vs Aug 24, 2021 | 144 | SEC filing |
| Aug 24, 2021 | Initial | $5,229,500 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.47M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-411096
Assumes maximum commissions earned. Excludes value of warrants to purchase a number and type of equity securities equal to up to 9% of the total equity securities ultimately issued upon conversion of the notes.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| National Securities Corporation | 7569 |
Source: Form D, filed Feb 4, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Brauns | Executive |
| Cameron Gray | Director |
| Dennis Hester | Executive |
| Anthony Japoul | Director, Executive |
| Anthony Japour | Director, Executive |
| Peter A. Kiener | Director |
| Camillo Ricordi | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1951 Nw 7 Th Ave., #600
Miami, FL, 33137
Miami, FL, 33137